Oral immunization with recombinant Yersinia enterocolitica expressing a measles virus CD4 T cell epitope protects against measles virus-induced encephalitis

Journal of General Virology

Volumn 84, Issue 4, 2003, Pages 775-779

  Gundel, Iris ^a   Weidinger, Gerald ^a   ter Meulen, Volker ^a   Heesemann, Jürgen ^a   Rüssmann, Holger ^b   Niewiesk, Stefan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; LIVE VACCINE; NUCLEOCAPSID PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EXPRESSION VECTOR; IMMUNIZATION; IMMUNOPROPHYLAXIS; MEASLES VIRUS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SHORT SURVEY; TH1 CELL; VIRUS ENCEPHALITIS; YERSINIA ENTEROCOLITICA;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALITIS, VIRAL; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; MEASLES; MEASLES VACCINE; MICE; MICE, INBRED C3H; MORBILLIVIRUS; NUCLEOCAPSID PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; VACCINATION; VACCINES, SYNTHETIC; YERSINIA ENTEROCOLITICA;

ANIMALIA; BACTERIA (MICROORGANISMS); MEASLES VIRUS; NEGIBACTERIA; RNA VIRUSES; YERSINIA ENTEROCOLITICA;

EID: 0037385303     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18834-0     Document Type: Short Survey

References (21)

1. Bouche, F. B., Ertl, O. T. & Muller, C. P. (2002). Neutralizing B cell responses in measles. Viral Immunol 15, 451-472.
2. Fennelly, G. J., Flynn, J. A. L., ter Meulen, V., Liebert, U. G. & Bloom, B. R. (1995). Recombinant Bacille Calmette-Guerin priming against measles. J Infect Dis 172, 698-705.
3. Finke, D., Brinckmann, U. G., ter Meulen, V. & Liebert, U. G. (1995). Gamma interferon is a major mediator of the antiviral defense in experimental measles virus-induced encephalitis. J Virol 69, 5469-5474.
4. Hilleman, M. R. (2001). Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine 20, 651-665.
5. Igwe, E. I., Russmann, H., Roggenkamp, A., Noll, A., Autenrieth, I. B. & Heesemann, J. (1999). Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica. Infect Immun 67, 5500-5507.
6. Jacobi, C. A., Roggenkamp, A., Rakin, A., Zumbihl, R., Leitritz, L. & Heesemann, J. (1998). In vitro and in vivo expression studies of yopE from Yersinia enterocolitica using the gfp reporter gene. Mol Microbiol 30, 865-882.
7. Katz, M. (1995). Clinical spectrum of measles. In Measles Virus, pp. 1-12. Edited by M. Billeter & V. ter Meulen. Berlin: Springer.
8. + T cells depends on the H-2 molecule. J Gen Virol 79, 2583-2591.
9. Niewiesk, S., Brinckmann, U., Bankamp, B., Sirak, S., Liebert, U. G. & ter Meulen, V. (1993). Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. J Virol 67, 75-81.
10. Polack, F. P., Auwaerter, P. G., Lee, S.-H., Nousari, H. C., Valsamakis, A., Leiferman, K. M., Diwan, A., Adams, R. J. & Griffin, D. E. (1999). Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 5, 629-634.
11. Polack, F. P., Hoffman, S. J., Moss, W. J. & Griffin, D. E. (2002). Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis 185, 13-19.
12. + T cells control measles virus infection of the central nervous system. Immunology 76, 185-191.
13. Roggenkamp, A., Bittner, T., Leitritz, L., Sing, A. & Heesemann, J. (1997). Contribution of the Mn-cofactored superoxide dismutase (SodA) to the virulence of Yersinia enterocolitica serotype O8. Infect Immun 65, 4705-4710.
14. Russmann, H., Weissmuller, A., Geginat, G., Igwe, E. I., Roggenkamp, A., Bubert, A., Goebel, W., Hof, H. & Heesemann, J. (2001). Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation. Eur J Immunol 30, 1375-1384.
15. Schlereth, B., Rose, K. J., Buonocore, L., ter Meulen, V. & Niewiesk, S. (2000). Successful vaccine-induced seroconversion by single dose immunization in the presence of measles virus specific maternal antibodies. J Virol 74, 4652-4657.
16. Spreng, S., Gentschev, I., Goebel, W., Weidinger, G., ter Meulen, V. & Niewiesk, S. (2000). Salmonella vaccines secreting measles virus epitopes induce protective immune responses against measles virus encephalitis. Microbes Infect 2, 1687-1692.
17. Tober, C., Seufert, M., Schneider, H., Billeter, M. A., Johnston, I. C. D., Niewiesk, S., ter Meulen, V. & Schneider-Schaulies, S. (1998). Expression of measles virus V protein is associated with transcriptional control and pathogenicity. J Virol 72, 8124-8132.
18. van Els, C. A. C. M. & Nanan, R. (2002). T cell responses in acute measles. Viral Immunol 15, 435-450.
19. Weidinger, G. (2002). Measles virus-specific T cell immunity in rodent models. Viral Immunol 15, 429-434.
20. + T cells in the prevention of measles virus induced encephalitis in mice. J Gen Virol 81, 2707-2713.
21. Weidinger, G., Henning, G., ter Meulen, V. & Niewiesk, S. (2001). Inhibition of major histocompatibility complex class II-dependent antigen presentation by neutralization of gamma interferon leads to breakdown of resistance against measles virus-induced encephalitis. J Virol 75, 3059-3065.